Worth reading
54Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
500000
sharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise of the 16th Stock Acquisition Rights issued through a third-party allotment (with Exercise Price Adjustment Clause)
Who receives how much500,000Shares
500,000 new shares
Macquarie Bank Limited (at the time of issuance on 9 April 2025)
The lower thin line represents the existing number of shares to which these shares will be added.
発行済株式総数
Approximately 0.17% (500,000 shares delivered / 297,121,340 issued shares as of the end of the month preceding the relevant month)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise price on 27 October 2026: ¥16.0. A provision provides for revision to an amount equivalent to 92% of the closing price on the preceding trading day.
Number of Stock Acquisition Rights
Total issued: 50,000 rights; exercised since the previous disclosure: 5,000 rights; unexercised balance as of the present: 5,000 rights
Basis for determining the amount to be paid
The exercise price is revised to an amount equivalent to 92% of the closing price on the trading day preceding the date on which the Company receives notice of each exercise request, with amounts of less than ¥1 rounded down.
Most recent equity financing
Announced 24 March 2025: Issuance of Series 15 and Series 16 Stock Acquisition Rights with exercise-price adjustment provisions through a third-party allotment, and unsecured bonds (privately placed bonds) (detailed amount: Not disclosed in this document)
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise of the 16th Stock Acquisition Rights issued through a third-party allotment (with Exercise Price Adjustment Clause) |
| Number of shares to be issued or disposed of | 500,000 new shares |
| Intended allottee | Macquarie Bank Limited (at the time of issuance on 9 April 2025) |
| Dilution Rate | Approximately 0.17% (500,000 shares delivered / 297,121,340 issued shares as of the end of the month preceding the relevant month) |
| Total number of issued shares | 297,121,340 shares (as of the end of the month preceding the month covered) → Not disclosed |
| Basis for determining the amount to be paid | The exercise price is revised to an amount equivalent to 92% of the closing price on the trading day preceding the date on which the Company receives notice of each exercise request, with amounts of less than ¥1 rounded down. |
| Exercise price | Exercise price on 27 October 2026: ¥16.0. A provision provides for revision to an amount equivalent to 92% of the closing price on the preceding trading day. |
| Number of Stock Acquisition Rights | Total issued: 50,000 rights; exercised since the previous disclosure: 5,000 rights; unexercised balance as of the present: 5,000 rights |
| Most recent equity financing | Announced 24 March 2025: Issuance of Series 15 and Series 16 Stock Acquisition Rights with exercise-price adjustment provisions through a third-party allotment, and unsecured bonds (privately placed bonds) (detailed amount: Not disclosed in this document) |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This was due to the large-scale exercise on 27 October 2026 of the Series 16 Stock Acquisition Rights issued on 9 April 2025.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.